Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey
Cheryl Vidall, Florian Scotté(University of Derby), Paz Fernández‐Ortega(Institut Català d'Oncologia), Bharat Amlani(Norgine (United Kingdom)), Patrick Jahn, Diego Cortinovis(Azienda Ospedaliera San Gerardo)
Cited by 58
Related Papers
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
|Annals of Oncology|2020|319
Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life
|Supportive Care in Cancer|2012|175
Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide
|Annals of Oncology|2018|169